Participants with lower BMI, classified as normal weight, and lower FGF21 being in the 25th percentile of the sample had a greater decrease in depression severity as measured by the HAMD-17 compared to those with higher FGF21 being in the 75th percentile of the sample. This evidence concerns the gene FGF21 and major depressive disorder.